Drug intelligence / Profile preview

E-GREEN

Development stage: Unknown
Lead developer: Ergon Pharmaceuticals
Administration: Oral

Overview

E-GREEN is an Ayurvedic herbal medicine developed and manufactured by Ergon Pharmaceuticals, a Bangladesh-based company. The product is formulated as a capsule containing 500 mg of refined Asparagus racemosus (Shatavari) powder. It is primarily indicated for the treatment of urinary tract infections (UTI) and for supporting the immune system. Additionally, E-GREEN is used in traditional medicine for a variety of conditions including oliguria, renal and sexual weakness, spermatorrhoea, leucorrhoea, and gastrointestinal issues such as dysentery, acidity, and chronic abdominal pain. Its therapeutic profile is derived from the phytochemical properties of Asparagus racemosus, which is recognized in Ayurveda for its rejuvenating and anti-inflammatory effects.

Brand names: E-GREENCapsule E-GREEN
Other names: Asparagus racemosus capsule

Beyond the preview

Go deeper on E-GREEN.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on E-GREEN.

Explore the full profile